Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 6/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.78 |
| ▸ | ATP6V1B2 | P21281 | 1/20 | 0.78 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.78 |
| ▸ | EDNRA | P25101 | 1/20 | 0.78 |
| ▸ | TARBP2 | Q15633 | 1/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | HPGD | P15428 | 5/20 | 0.50 |
| ▸ | BRD4 | O60885 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | TOP2A | P11388 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10703698 | 0.90 | LMNA (0.63) | LMNACYP2C9ATP6V1B2TBXA2REDNRA | |
| Asparagine SCHEMBL11011678 | 0.90 | LMNA (0.64) | LMNACYP2C9ATP6V1B2TBXA2REDNRA | |
| SCHEMBL10913668 | 0.89 | LMNA (0.71) | LMNACYP2C9ATP6V1B2TBXA2REDNRA | |
| Glutamic Acid SCHEMBL11015624 | 0.89 | LMNA (0.63) | LMNACYP2C9ATP6V1B2TBXA2REDNRA | |
| SCHEMBL11324091 | 0.88 | LMNA (0.61) | LMNACYP2C9ATP6V1B2TBXA2REDNRA | |
| Enoxacin SCHEMBL33963 | 0.88 | LMNA (1.00) | LMNACYP2C9ATP6V1B2TBXA2REDNRA | |
| Enoxacin SCHEMBL29384458 | 0.88 | LMNA (1.00) | LMNACYP2C9ATP6V1B2TBXA2REDNRA | |
| Enoxacin SCHEMBL2635855 | 0.88 | LMNA (1.00) | LMNACYP2C9ATP6V1B2TBXA2REDNRA | |
| Glucuronic Acid SCHEMBL11007046 | 0.88 | LMNA (0.61) | LMNACYP2C9ATP6V1B2TBXA2REDNRA | |
| Enoxacin SCHEMBL11289413 | 0.87 | LMNA (0.98) | LMNACYP2C9ATP6V1B2TBXA2REDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1408034-B1 | Use of Quinolone and Quinolizinone derivatives as chemotherapeutic agents | SCHULZ & SCHLIMBACH GBR (DE) | 2007-08-08 | — | — | EP | claimed |
| EP-1143950-B1 | TOPICAL APPLICATION PRODUCTS AGAINST ONYCHOMYCOSES | BIOEQUAL AG (CH) | 2005-03-09 | — | — | EP | claimed |
| EP-1408034-A1 | Use of Quinoline derivatives as antibacterial agents | Schulz & Schlimbach GbR (DE) | 2004-04-14 | — | — | EP | claimed |
| EP-1244434-A2 | USE OF CHEMOTHERAPEUTIC AGENTS | Schulz, Hans-Herrmann (DE) | 2002-10-02 | — | — | EP | claimed |
| WO-2001045679-A2 | USE OF CHEMOTHERAPEUTIC AGENTS FOR TOPICAL TREATMENT | SCHULZ HANS HERRMANN (DE) | 2001-06-28 | — | — | WO | claimed |
| EP-0240391-B1 | SILVER SALT DERIVED FROM NAPHTHYRIDINE, USEFUL AS A BACTERICIDE, PROCESS FOR ITS PREPARATION AND COMPOSITIONS CONTAINING IT | EDMOND PHARMA S.R.L. (IT) | 1991-07-10 | — | — | EP | claimed |
| EP-0210513-A1 | Preparations for the treatment of mycoplasmoses and bacterial infections in poultry | BAYER AG (DE) | 1987-02-04 | — | — | EP | claimed |
| EP-0058614-B1 | 1-ETHYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-(1-PIPERAZINYL)-1,8 NAPHTYRIDINE-3-CARBOXYLIC ACID. SESQUIHYDRATE, PROCESSES FOR THE PREPARATION THEREOF AND USE THEREOF AS ANTIBACTERIAL AGENTS | Société anonyme dite: LABORATOIRE ROGER BELLON (FR) | 1985-09-18 | — | — | EP | claimed |
| EP-0009425-B1 | NOVEL NAPHTYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | Société anonyme dite: LABORATOIRE ROGER BELLON (FR) | 1982-01-27 | — | — | EP | claimed |
| EP-1682144-B1 | PHARMACEUTICAL FORMULATIONS CONTAINING FLAVOURING SUBSTANCES WITH IMPROVED PHARMACEUTICAL PROPERTIES | BAYER ANIMAL HEALTH GMBH (DE) | 2010-01-13 | — | — | EP | disclosed |
| EP-2080515-A1 | Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties | Bayer Animal Health GmbH (DE) | 2009-07-22 | — | — | EP | disclosed |
| EP-1680076-B1 | PHARMACEUTICAL AND COSMETIC FORMULATIONS FOR TREATING FINGERNAILS | BIOEQUAL AG (CH) | 2008-07-02 | — | — | EP | disclosed |
| EP-1408034-B1 | Use of Quinolone and Quinolizinone derivatives as chemotherapeutic agents | SCHULZ & SCHLIMBACH GBR (DE) | 2007-08-08 | — | — | EP | disclosed |
| EP-1682144-A1 | PHARMACEUTICAL FORMULATIONS CONTAINING FLAVOURING SUBSTANCES WITH IMPROVED PHARMACEUTICAL PROPERTIES | Bayer HealthCare AG (DE) | 2006-07-26 | — | — | EP | disclosed |
| EP-0138018-B1 | SOLUTIONS OF LACTIC ACID SALTS OF PIPERAZINYLQUINOLONE AND PIPERAZINYL AZAQUINOLONECARBOXYLIC ACIDS | BAYER AG (DE) | 1988-11-02 | — | — | EP | disclosed |
| EP-0210513-A1 | Preparations for the treatment of mycoplasmoses and bacterial infections in poultry | BAYER AG (DE) | 1987-02-04 | — | — | EP | disclosed |
| EP-0205029-A2 | Quinolinecarboxylic acids with an antibacterial activity | BAYER AG (DE) | 1986-12-17 | — | — | EP | disclosed |
| EP-0187315-A2 | Basic quinolonecarboxylic-acid preparations | BAYER AG (DE) | 1986-07-16 | — | — | EP | disclosed |
| EP-0187376-A2 | 6,7-Disubstituted 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids | BAYER AG (DE) | 1986-07-16 | — | — | EP | disclosed |
| EP-0138018-A2 | Solutions of lactic acid salts of piperazinylquinolone and piperazinyl azaquinolonecarboxylic acids | BAYER AG (DE) | 1985-04-24 | — | — | EP | disclosed |